Comprehensive analysis of TEAD inhibition in meningioma identifies MEK and mTOR inhibition as effective combination therapies against resistant lines.
Dylan J Keiser, Meghan S Buddy, Solmaz Mojarad-Jabali…·Frank Szulzewsky
This study identifies TEAD inhibition as a therapeutic target in meningioma and shows that combining MEK and mTOR inhibition overcomes resistance in resistant lines.